| No COVID-19 (n = 96) | COVID-19 (n = 130) | SMD |
Age (years, mean) | 68.3 | 67.2 | 0.07 |
Female (%) | 34.3 | 32.4 | 0.04 |
Body mass index (kg/m2, mean) | 23.7 | 24.1 | 0.08 |
Symptomatic stroke (%) | 9.6 | 7.6 | 0.07 |
Chronic heart failure (%) | 6.1 | 3.9 | 0.10 |
Ischemic heart disease (%) | 13.8 | 11.3 | 0.07 |
Hypertension (%) | 50.2 | 52.9 | 0.05 |
Diabetes mellitus (%) | 26.6 | 25.2 | 0.03 |
Atrial fibrillation (%) | 5.3 | 5.4 | 0.01 |
Chronic lung disease (%) | 23.5 | 25.6 | 0.04 |
Chronic kidney disease (%) | 21.3 | 20.4 | 0.02 |
Hematologic disease (%) | 5.3 | 5 | 0.01 |
Connective tissue disease (%) | 6.4 | 10.2 | 0.13 |
Hepatic failure (%) | 8.9 | 7 | 0.06 |
Solid cancer (%) | 26.1 | 29.6 | 0.08 |
Benzodiazepines before hospitalization (%) | 5.4 | 6.8 | 0.05 |